Dynamic Technology Lab Boosts Omnicell Stake by 346%

The investment firm increased its holdings in the healthcare technology company in Q3 2025.

Published on Mar. 9, 2026

Dynamic Technology Lab Private Ltd lifted its stake in Omnicell, Inc. (NASDAQ:OMCL) by 345.9% in the third quarter, according to a recent SEC filing. The firm now owns 31,890 shares of the company's stock, up from 7,152 shares previously.

Why it matters

Omnicell is a leading provider of medication management solutions for hospitals, clinics, and pharmacies. The significant increase in Dynamic Technology Lab's stake suggests the firm sees strong growth potential in Omnicell's business and technology offerings.

The details

According to the 13F filing, Dynamic Technology Lab acquired an additional 24,738 shares of Omnicell during the third quarter, bringing its total holdings to 31,890 shares. This represents approximately 0.07% ownership of the company. The investment firm cited Omnicell's innovative medication management solutions and growth prospects as factors behind the increased stake.

  • Dynamic Technology Lab filed the 13F report disclosing the stake increase on March 9, 2026.
  • The firm acquired the additional 24,738 shares during the third quarter of 2025.

The players

Dynamic Technology Lab Private Ltd

An investment firm that has increased its stake in Omnicell, a healthcare technology company specializing in medication management solutions.

Omnicell, Inc.

A healthcare technology company that provides automated dispensing cabinets, pharmacy automation systems, and software platforms to optimize medication usage and workflow in hospitals, clinics, and pharmacies.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee (Instagram)

The takeaway

The significant increase in Dynamic Technology Lab's stake in Omnicell highlights the investment firm's confidence in the healthcare technology company's growth potential and innovative medication management solutions, which are crucial for hospitals, clinics, and pharmacies.